265 related articles for article (PubMed ID: 35583844)
1. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
[TBL] [Abstract][Full Text] [Related]
2. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
[TBL] [Abstract][Full Text] [Related]
3. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
[TBL] [Abstract][Full Text] [Related]
5. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
6. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
7. Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
Repetto M; Crimini E; Giugliano F; Morganti S; Belli C; Curigliano G
Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1233-1252. PubMed ID: 34591728
[No Abstract] [Full Text] [Related]
8. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of FGFR-mediated carcinogenesis.
Ahmad I; Iwata T; Leung HY
Biochim Biophys Acta; 2012 Apr; 1823(4):850-60. PubMed ID: 22273505
[TBL] [Abstract][Full Text] [Related]
11. FGF/FGFR signaling in bone formation: progress and perspectives.
Marie PJ; Miraoui H; Sévère N
Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
[TBL] [Abstract][Full Text] [Related]
12. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
Flippot R; Kone M; Magné N; Vignot S
Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics.
Parish A; Schwaederle M; Daniels G; Piccioni D; Fanta P; Schwab R; Shimabukuro K; Parker BA; Helsten T; Kurzrock R
Cell Cycle; 2015; 14(13):2121-8. PubMed ID: 25950492
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
Hierro C; Rodon J; Tabernero J
Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
Czyz M
Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
Salgia R
Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
[TBL] [Abstract][Full Text] [Related]
18. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives.
Loda A; Turati M; Semeraro F; Rezzola S; Ronca R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409195
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical fibroblast growth factor signalling in angiogenesis.
Murakami M; Elfenbein A; Simons M
Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
[TBL] [Abstract][Full Text] [Related]
20. FGF/FGFR signaling: From lung development to respiratory diseases.
Yang L; Zhou F; Zheng D; Wang D; Li X; Zhao C; Huang X
Cytokine Growth Factor Rev; 2021 Dec; 62():94-104. PubMed ID: 34593304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
